Every SEC Form 3/4/5 on record for this filer (CIK 1258360) — 4 issuers, 18 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | Chief Executive Officer · Director | 2021-11-18 → 2025-12-18 | 8 | $70,700 |
| HJLI | Hancock Jaffe Laboratories, Inc. | Chief Executive Officer · Director · lapsed | 2018-05-30 → 2021-05-19 | 8 | $66,411 |
| ITUS | ITUS Corp | President & CEO · Director · lapsed | 2015-07-24 → 2017-06-05 | 4 | $37,647 |
| ITUSD | ITUS Corp | President and CEO · Director · lapsed | 2015-07-01 → 2015-07-14 | 4 | $13,043 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| NVNO | 2024-12-19 | Buy | 12,000 | $2.55 | $30,600 | 222,236 |
| NVNO | 2022-06-27 | Buy | 2,500 | $3.80 | $9,500 | 210,236 |
| NVNO | 2021-11-19 | Buy | 2,000 | $7.43 | $14,860 | 7,736 |
| NVNO | 2021-11-16 | Buy | 2,000 | $7.87 | $15,740 | 5,736 |
| HJLI | 2021-05-18 | Buy | 3,000 | $5.47 | $16,410 | 3,736 |
| HJLI | 2019-03-12 | Buy | 21,740 | $1.15 | $25,001 | 21,740 |
| HJLI | 2019-03-12 | Buy | 18,382 | $1.36 | $25,000 | 18,382 |
| ITUS | 2017-06-02 | Buy | 100 | $0.85 | $85 | 51,653 |
| ITUS | 2017-06-02 | Buy | 9,900 | $0.88 | $8,712 | 61,553 |
1 of 4 issuers are covered and open a security page; the rest are on file here only.
